Merck China Unit Begins Expansion Of Shanghai Production Plant
This article was originally published in PharmAsia News
Executive Summary
The China unit of U.S.-based Merck - Merck Sharp & Dohme - began expanding its Shanghai production plant as part of a $162 million expansion plan in the country